P1510: VAMIFEPORT PREVENTED THE FORMATION OF NON-TRANSFERRIN-BOUND IRON IN A MOUSE MODEL OF ΒETA-THALASSEMIA WITH BLOOD TRANSFUSIONS

P1510: VAMIFEPORT PREVENTED THE FORMATION OF NON-TRANSFERRIN-BOUND IRON IN A MOUSE MODEL OF ΒETA-THALASSEMIA WITH BLOOD TRANSFUSIONS

Bibliographic Details
Main Authors:	N. Kalleda, A. Flace, P. Altermatt, G. Ingoglia, C. Doucerain, N. Nyffenegger, F. Dürrenberger, V. Manolova
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000848896.47474.26

Similar Items

The Oral Ferroportin Inhibitor VIT-2763 Improves Erythropoiesis without Interfering with Iron Chelation Therapy in a Mouse Model of β-Thalassemia
by: Naja Nyffenegger, et al.
Published: (2021-01-01)

Structures of ferroportin in complex with its specific inhibitor vamifeport
by: Elena Farah Lehmann, et al.
Published: (2023-03-01)

The (Bio)Chemistry of Non-Transferrin-Bound Iron
by: André M. N. Silva, et al.
Published: (2022-03-01)

S272: SAFETY AND PRELIMINARY PHARMACODYNAMIC EFFECTS OF THE FERROPORTIN INHIBITOR VAMIFEPORT (VIT-2763) IN PATIENTS WITH NON-TRANSFUSION-DEPENDENT BETA THALASSEMIA (NTDT): RESULTS FROM A PHASE 2A STUDY
by: A. Taher, et al.
Published: (2022-06-01)

S270: TRANSFUSION INDEPENDENCE AFTER EXAGAMGLOGENE AUTOTEMCEL IN PATIENTS WITH TRANSFUSION-DEPENDENT ΒETA-THALASSEMIA
by: Franco Locatelli, et al.
Published: (2023-08-01)

Iron overload in non-transfusion-dependent thalassemia
by: Khaled M. Musallam
Published: (2013-03-01)

Significant Inverse Correlation of Serum Levels of Osteoprotegerin (OPG) and Transferrin Saturation in Thalassemia Dependent Transfusion (TDT) Patients
by: Indra Wijaya, et al.
Published: (2024-01-01)

Correlation of Transferrin Saturation and Serum Ferritin with Bone Mass Density in Adult Transfusion Dependent Beta-Thalassemia Patients
by: Atmakusuma TD, et al.
Published: (2021-09-01)

P1558: EARLY-START DEFERIPRONE IN INFANTS/YOUNG CHILDREN WITH TRANSFUSION-DEPENDENT BETA THALASSEMIA: EVIDENCE FOR IRON SHUTTLING TO TRANSFERRIN—RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL (START)
by: F. Tricta, et al.
Published: (2022-06-01)

Determination of Non-Transferrin Bound Iron, Transferrin Bound Iron, Drug Bound Iron and Total Iron in Serum in a Rats after IV Administration of Sodium Ferric Gluconate Complex by Simple Ultrafiltration Inductively Coupled Plasma Mass Spectrometric Detection
by: Murali K. Matta, et al.
Published: (2018-02-01)

Iron Chelator Drugs in Transfusion Dependent Thalassemia: a Review
by: M Hashemieh
Published: (2020-08-01)

Understanding Iron Metabolism: Lessons from Transfusion-dependent Thalassemia
by: Murtadha Al-Khabori, et al.
Published: (2018-01-01)

Sandro Botticelli (1445-1510)
Published: (2023-03-01)

P1741: EXAMINING THE BURDEN OF ILLNESS ASSOCIATED WITH TRANSFUSION-DEPENDENT ΒETA-THALASSEMIA FROM THE PATIENT’S PERSPECTIVE
by: R. L. Knoth, et al.
Published: (2022-06-01)

Quality of life: Transfusion dependent thalassemia vs non-transfusion dependent thalassemia
by: Mehran Karimi, et al.
Published: (2018-04-01)

THALIDOMIDE AMELIORATES ERYTHROPOIESIS AND IRON HOMEOSTASIS IN TRANSFUSION-DEPENDENT β-THALASSEMIA
by: Kun Yang, et al.
Published: (2024-01-01)

Iron overload status in patients with non-transfusion-dependent thalassemia in China
by: Yumei Huang, et al.
Published: (2022-03-01)

Neoplastic transformation of rat liver epithelial cells is enhanced by non-transferrin-bound iron
by: Messner Donald J, et al.
Published: (2008-02-01)

Quantitative label-free imaging of iron-bound transferrin in breast cancer cells and tumors
by: Ting Chean Khoo, et al.
Published: (2020-09-01)

Evaluation of the Association of Transferrin Receptor Type 2 Gene Mutation (Y250X) with Iron Overload in Major β-Thalassemia
by: J Abdulmalek Jaafar, et al.
Published: (2021-11-01)

Soluble transferrin receptor and immature reticulocytes are not useful for distinguishing iron-deficiency anemia from heterozygous beta-thalassemia
by: Gisélia Aparecida Freire Maia de Lima, et al.

Non-transferrin plasma iron.
by: Hershko, C, et al.
Published: (1987)

Transfusion regimens in thalassemia intermedia
by: Z. Karakas
Published: (2011-12-01)

Osteoporosis in Transfusion Dependent Thalassemia
by: Mozhgan Hashemieh
Published: (2019-11-01)

Pulmonary function in patients with transfusion-dependent thalassemia and its associations with iron overload
by: Kate C. Chan, et al.
Published: (2023-03-01)

Barriers to adherence to iron chelation therapy among adolescent with transfusion dependent thalassemia
by: Rafaa Mohamed, et al.
Published: (2022-10-01)

Differences in circulating non-transferrin-bound iron after oral administration of ferrous sulfate, sodium iron EDTA, or iron polymaltose in women with marginal iron stores
by: K. Schümann, et al.
Published: (2017-10-01)

PB2238: ΒETA-THALASSEMIA INTERMEDIA: INTERACTION OF ΑLPHA-GLOBIN GENE TRIPLICATION WITH ΒETA-THALASSEMIA HETEROZYGOUS IN SPAIN
by: P. Ropero, et al.
Published: (2022-06-01)

P1454: CLINICAL DETERMINANTS OF CARDIAC IRON IN REGULARLY TRANSFUSED THALASSEMIA INTERMEDIA PATIENTS
by: Antonella Meloni, et al.
Published: (2023-08-01)

Link between Genotype and Multi-Organ Iron and Complications in Children with Transfusion-Dependent Thalassemia
by: Antonella Meloni, et al.
Published: (2022-03-01)

Iron chelation therapy in transfusion-dependent thalassemia patients: current strategies and future directions
by: Saliba AN, et al.
Published: (2015-06-01)

Reducing the iron burden and improving survival in transfusion-dependent thalassemia patients: current perspectives
by: Bayanzay K, et al.
Published: (2016-08-01)

Brazilian Thalassemia Association protocol for iron chelation therapy in patients under regular transfusion
by: Monica Pinheiro de Almeida Verissimo, et al.
Published: (2013-01-01)

Endogenous hepcidin and its agonist mediate resistance to selected infections by clearing non-transferrin-bound iron
by: Stefanova, D, et al.
Published: (2017)

Safety and Efficacy of the New Combination Iron Chelation Regimens in Patients with Transfusion-Dependent Thalassemia and Severe Iron Overload
by: Raffaella Origa, et al.
Published: (2022-04-01)

Targeting the Second Transferrin Receptor as Emerging Therapeutic Option for β-Thalassemia Major
by: Francesca Vinchi, et al.
Published: (2022-11-01)

The Vanishing of the Primary Emission Region in PKS 1510–089
by: F. Aharonian, et al.
Published: (2023-01-01)

Non-transfusion dependent thalassemia: translating evidence to guidelines
by: Afif R. Harb, et al.
Published: (2014-12-01)

P1563: INTRACELLULAR IRON OVERLOAD IMPAIRS HSC FUNCTION BY AFFECTING MITOCHONDRIAL FITNESS IN ΒETA-THALASSEMIA
by: S. Sighinolfi, et al.
Published: (2022-06-01)

Multiwavelength Temporal Variability of the Blazar PKS 1510–089
by: Q. Yuan, et al.
Published: (2023-01-01)